Verve Therapeutics Stock (NASDAQ:VERV), Quotes and News Summary

Q: What sector and industry does Verve Therapeutics (VERV) operate in?

Verve Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Verve Therapeutics Stock (NASDAQ: VERV) stock price, news, charts, stock research, profile.

Open	$6.590
Close	$6.640
Volume / Avg.	1.098M / 1.275M
Day Range	6.420 - 6.800
52 Wk Range	6.530 - 21.420
Market Cap	$555.232M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	21
Short Interest	23.71%
Days to Cover	21.5

Recent News

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Avi Kapoor

Cathie Wood's Ark Invest Sheds $6.4M Worth Of Coinbase Shares Despite Positive Market Movements, Analyst Upgrade

On Thursday, Cathie Wood-led Ark Invest made a significant move by selling shares of Coinbase Global Inc (NASDAQ:COIN), despite the stock’s positive market performance on the same day. The COIN Trade

Benzinga Neuro

Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More

Pipeline and regulatory updates continue to be in focus in the biotech sector. While nothing much came out of bigwigs apart from a few, shares of clinical-stage biotechs like Disc Medicine, Inc.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Verve Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardi...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Verve Therapeutics (VERV) stock?

You can purchase shares of Verve Therapeutics (NASDAQ: VERV) through any online brokerage.

View our list of the best stock brokerages.

Who are Verve Therapeutics's (VERV) competitors?

Other companies in Verve Therapeutics’s space includes: Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC), Korro Bio (NASDAQ:KRRO), Altimmune (NASDAQ:ALT) and Fate Therapeutics (NASDAQ:FATE).

What is the target price for Verve Therapeutics (VERV) stock?

The latest price target for Verve Therapeutics (NASDAQ: VERV) was reported by Stifel on Wednesday, April 3, 2024. The analyst firm set a price target for 40.00 expecting VERV to rise to within 12 months (a possible 502.41% upside). 8 analyst firms have reported ratings in the last year.

Current Stock Price for Verve Therapeutics (VERV)?

The stock price for Verve Therapeutics (NASDAQ: VERV) is $6.64 last updated April 19, 2024 at 6:52 PM EDT.

Does Verve Therapeutics (VERV) pay a dividend?

There are no upcoming dividends for Verve Therapeutics.

When is Verve Therapeutics (NASDAQ:VERV) reporting earnings?

Verve Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Is Verve Therapeutics (VERV) going to split?

There is no upcoming split for Verve Therapeutics.

What sector and industry does Verve Therapeutics (VERV) operate in?

Verve Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-